Calcineurin Inhibitors and COVID-19

被引：0
|
作者：
Hage, Rene [1 ,2 ]
Schuurmans, Mace M. [1 ,2 ]
机构：
[1] Univ Hosp Zurich, Div Pulmonol, Raemistr 100, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Fac Med, Raemistr 71, CH-8006 Zurich, Switzerland
来源：
REUMATOLOGIA CLINICA | 2022年 / 18卷 / 05期
关键词：
REPLICATION; COV;
D O I：
10.1016/j.reuma.2020.09.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：314 / 315
页数：2
相关论文
共 50 条
  • [1] Calcineurin inhibitors revisited: A new paradigm for COVID-19?
    Hage, Rene
    Steinack, Carolin
    Schuurmans, Mace M.
    [J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2020, 24 (04): : 365 - 367
  • [2] COVID-19 survivors with calcineurin-inhibitors-treated rheumatoid arthritis
    Kobayashi, Hiroshi
    Hirai, Yuji
    Aoki, Akiko
    [J]. MODERN RHEUMATOLOGY CASE REPORTS, 2022, 6 (01) : 10 - 13
  • [3] COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?
    Willicombe, Michelle
    Thomas, David
    McAdoo, Stephen
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (06): : 1145 - 1146
  • [4] Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients
    Hasbal, Nuri Baris
    Turgut, Didem
    Oguz, Ebru Gok
    Ulu, Sena
    Gungor, Ozkan
    [J]. ANNALS OF TRANSPLANTATION, 2021, 26
  • [5] JAK inhibitors and COVID-19
    Levy, Gabriel
    Guglielmelli, Paola
    Langmuir, Peter
    Constantinescu, Stefan
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (04)
  • [6] Promises and Pitfalls of Calcineurin Inhibitors in COVID-19: A Systematic Review and Meta-analysis of Controlled Trials
    Heydari, Behrooz
    Sahebnasagh, Adeleh
    Omrani, Mohammad Ali
    Azimi, Saeed
    Dehghani, Mohammad Hossein
    Salehi-Abargouei, Amin
    Farman, Farnoosh
    Saghafi, Fatemeh
    [J]. CURRENT MEDICINAL CHEMISTRY, 2024, 31 (29) : 4745 - 4755
  • [7] Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry
    Calderon-Parra, Jorge
    Cuervas-Mons, Valentin
    Moreno-Torres, Victor
    Rubio-Rivas, Manuel
    Agudo-de Blas, Paloma
    Pinilla-Llorente, Blanca
    Helguera-Amezua, Cristina
    Jimenez-Garcia, Nicolas
    Pesqueira-Fontan, Paula-Maria
    Mendez-Bailon, Manuel
    Artero, Arturo
    Gilabert, Noemi
    Ibanez-Estellez, Fatima
    Freire-Castro, Santiago-Jesus
    Lumbreras-Bermejo, Carlos
    Anton-Santos, Juan-Miguel
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : 51 - 58
  • [8] RAAS Inhibitors and Risk of Covid-19
    Islam, Nazrul
    Khunti, Kamlesh
    Chowell, Gerardo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20): : 1992 - 1992
  • [9] COVID-19 and immune checkpoint inhibitors
    Ahmed, M. S.
    Brehme, H.
    Friedrich, S.
    Reinhardt, L.
    Blum, S.
    Beissert, S.
    Meier, F.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (05) : E312 - E314
  • [10] Tyrosine kinase inhibitors and COVID-19
    Semih, Basci
    Tugce Nur, Yigenoglu
    Mehmet Sinan, Dal
    Serdal, Korkmaz
    Burhan, Turgut
    Fevzi, Altuntas
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (08) : 2072 - 2073
12345